跳至主要内容
临床试验/EUCTR2018-001277-24-NL
EUCTR2018-001277-24-NL进行中(未招募)1 期

Microvascular Recovery in Acute MI, a single center, prospective, randomized, single blind parallel-group comparison of sonothrombolysis versus standard of care performed after (post) coronary reperfusion (primary PCI). - MRUSMI

VU University Medical Center (VUmc)0 个研究点目标入组 60 人开始时间: 2019年8月20日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Patients presenting with STEMI with:
  • - = 2mm ST-segment elevation in 2 anterior or lateral leads; or
  • - = 1 mm ST-segment elevation in 2 inferior leads
  • - = 1mm ST-segment elevation in lateral leads (I, aVL, V5, V6)
  • - Persistence of ST-elevation of more than 30% after PCI in the lead with the highest ST-elevation on the ECG after PCI compared to the ECG before PCI
  • - Within 12 hours of symptom onset
  • - Age = 30 years
  • - Adequate apical and/or parasternal images by echocardiography
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 30

排除标准

  • -Previous coronary bypass surgery
  • -Cardiogenic shock
  • -Known or suspected hypersensitivity to ultrasound contrast agent used for the study
  • -Life expectancy of less than two months or terminally ill
  • -Known bleeding diathesis or contraindication to glycoprotein IIB/IIIA inhibitors, anticoagulants or aspirin
  • -Known large right to left intracardiac shunts

研究者

发起方
VU University Medical Center (VUmc)

相似试验